Clinical trials
Observational Myocardial Ischemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese Academy of Medical Sciences, Fuwai Hospital | 3 |
| Shanghai Zhongshan Hospital | 3 |
| Beijing Hospital | 2 |
| Beijing Tiantan Hospital | 2 |
| Insight Lifetech Co., Ltd. | 2 |
| Qilu Hospital of Shandong University | 2 |
| BIOTRONIK Asia Pacific Pte Ltd | 1 |
| Beijing Anzhen Hospital | 1 |
| Beijing Institute of Heart, Lung and Blood Vessel Diseases | 1 |
| China National Center for Cardiovascular Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Ischemia | 30 |
| Coronary Artery Disease | 14 |
| Cardiovascular Diseases | 8 |
| Coronary Disease | 6 |
| Arteriosclerosis | 4 |
| Heart Diseases | 4 |
| Myocardial Infarction | 4 |
| Vascular Diseases | 4 |
| Arterial Occlusive Diseases | 3 |
| Heart Failure | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.